Literature DB >> 1001359

General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.

D P Vaughan, G T Tucker.   

Abstract

A constant plasma drug concentration can be achieved and maintained by the intravenous administration of an initial bolus loading dose in conjunction with a constant rate and an exponential intravenous drug infusion. The drug input required to achieve a constant plasma drug concentration is derived without making any assumptions about the nature of drug distribution within the body or elimination from the body.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001359     DOI: 10.1007/bf00563080

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Comparison of toxicity of intravenously given local anesthetic agents in man.

Authors:  F F FOLDES; R MOLLOY; P G McNALL; L R KOUKAL
Journal:  J Am Med Assoc       Date:  1960-04-02

2.  A dynamic concept of the distribution of thiopental in the human body.

Authors:  H L PRICE
Journal:  Anesthesiology       Date:  1960 Jan-Feb       Impact factor: 7.892

3.  Acute phase of myocardial infarction.

Authors:  A A Adgey; J D Allen; J S Geddes; R G James; S W Webb; S A Zaidi; J F Pantridge
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

4.  A hypothesis for the rapid attainment and maintenance of lidocaine plasma levels.

Authors:  D Shen; M Gibaldi
Journal:  J Clin Pharmacol       Date:  1974-07       Impact factor: 3.126

5.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

6.  Intramuscular lidocaine in the therapy of ventricular arrhythmias.

Authors:  S Bellet; L Roman; J B Kostis; D Fleischmann
Journal:  Am J Cardiol       Date:  1971-03       Impact factor: 2.778

7.  Problems of the pre-hospital phase of acute myocardial infarction.

Authors:  S Bondurant
Journal:  Am J Cardiol       Date:  1969-11       Impact factor: 2.778

8.  Continuous intravenous infusion and multicompartment accumulation.

Authors:  E Krüger-Thiemer
Journal:  Eur J Pharmacol       Date:  1968-10       Impact factor: 4.432

9.  Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction.

Authors:  M A Bennett; J M Wilner; B L Pentecost
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

10.  Duration of last attack in 998 fatal cases of coronary artery disease and its relation to possible cardiac resuscitation.

Authors:  R H McNeilly; J Pemberton
Journal:  Br Med J       Date:  1968-07-20
View more
  13 in total

1.  Rapid attainment of steady state plasma drug concentrations within precise limits.

Authors:  B Korman; L S Jennings; J R Rigg
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

2.  A computer-based system for controlling plasma opioid concentration according to patient need for analgesia.

Authors:  H F Hill; R C Jacobson; B A Coda; A M Mackie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

3.  An approximate model-independent method to maintain constant plasma levels of intravenous drugs.

Authors:  J M Bailey
Journal:  J Pharmacokinet Biopharm       Date:  1991-12

4.  Determination of the distribution volume that can be used to calculate the intravenous loading dose.

Authors:  D R Wada; D R Drover; H J Lemmens
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

Review 5.  Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Authors:  D P Vaughan; I Hope
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

6.  A model-independent proof of Dost's law of corresponding areas.

Authors:  D P Vaughan
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

7.  Rapid achievement of a serum concentration plateau of digoxin through controlled infusion.

Authors:  M Weiss; W Sziegoleit; A Fahr; W Förster
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

9.  Determination of pharmacokinetic constants after multiple infusions of drugs.

Authors:  L E Mather; R L Ringrose; K L Austin
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

10.  Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent.

Authors:  D P Crankshaw; N E Edwards; G L Blackman; M D Boyd; H N Chan; D J Morgan
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.